MedPath

The effect of hepatoheal tablet on non alcoholic fatty liver

Phase 2
Conditions
non alcoholic fatty liver.
Nonalcoholic fatty liver disease (NAFLD)
Registration Number
IRCT2014042612438N6
Lead Sponsor
Barij Research Center of Medicinal Herbs
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Inclusion criteria :Both sexes; age >18; fatty liver on ultra sound; 25< BMI<40
exclusion criteria :ast/alt<1; pregnancy; breast feeding; alcohol; hormonal disorders; other liver diseases; hepatotoxic drugs; diet or treatment for fatty liver in 3 month past; autoimmune diseases and cancers.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ALT. Timepoint: beginning and end of study. Method of measurement: blood test.;AST. Timepoint: beginning and end of study. Method of measurement: blood test.;ALP. Timepoint: beginning and end of study. Method of measurement: blood test.
Secondary Outcome Measures
NameTimeMethod
HOMA-IR. Timepoint: beginning and end of study. Method of measurement: blood test.
© Copyright 2025. All Rights Reserved by MedPath